This Program proposes an overarching hypothesis that rational targeting of ?-secretase, a multi-subunit intramembrane cleaving protease that has several biologically important substrates, may be considered as a therapeutic target for a number of diseases. The three projects in this Program address the use of ?-secretase inhibitors in breast cancer (Project 1), and graft-versus-host disease (Project 2), and propose biochemical strategies to enable us to better understand the mechanism of action of ?-secretase (Project 3). These projects are integrated with a goal of better understanding the mechanism of action of ?-secretase inhibition in normal, as well as, disease settings. The Principal Investigators of this Program have worked together, shared data and published as a group for the past six years. The Program is significantly enhanced by a Chemistry Core that has the proven ability to synthesize a wide variety of ?-secretase inhibitors that allow members of the Program to explore the biological properties of these inhibitors in an environment free from commercial restriction. Such an approach will provide a scientific basis for optimal GSI selection matched to a particular disease.
The development of y-secretase inhibitors targeted for therapy of diseases such as cancer and graft-versus host- disease is likely to significantly impact the treatment of these two important diseases.
|Ozay, E Ilker; Gonzalez-Perez, Gabriela; Torres, Joe A et al. (2016) Intracellular Delivery of Anti-pPKCÎ¸ (Thr538) via Protein Transduction Domain Mimics for Immunomodulation. Mol Ther 24:2118-2130|
|deRonde, Brittany M; Posey, Nicholas D; Otter, Ronja et al. (2016) Optimal Hydrophobicity in Ring-Opening Metathesis Polymerization-Based Protein Mimics Required for siRNA Internalization. Biomacromolecules 17:1969-77|
|Gordon, Mallory R; Canakci, Mine; Li, Longyu et al. (2015) Field Guide to Challenges and Opportunities in Antibody-Drug Conjugates for Chemists. Bioconjug Chem 26:2198-215|
|Yun, Jieun; Espinoza, Ingrid; Pannuti, Antonio et al. (2015) p53 Modulates Notch Signaling in MCF-7 Breast Cancer Cells by Associating With the Notch Transcriptional Complex Via MAML1. J Cell Physiol 230:3115-27|
|Kuksin, Christina Arieta; Minter, Lisa M (2015) The Link between Autoimmunity and Lymphoma: Does NOTCH Signaling Play a Contributing Role? Front Oncol 5:51|
|Park, Hyo-Jin; Ran, Yong; Jung, Joo In et al. (2015) The stress response neuropeptide CRF increases amyloid-Î² production by regulating Î³-secretase activity. EMBO J 34:1674-86|
|Wongchana, Wipawee; Lawlor, Rebecca G; Osborne, Barbara A et al. (2015) Impact of Notch1 Deletion in Macrophages on Proinflammatory Cytokine Production and the Outcome of Experimental Autoimmune Encephalomyelitis. J Immunol 195:5337-46|
|deRonde, Brittany M; Torres, Joe A; Minter, Lisa M et al. (2015) Development of Guanidinium-Rich Protein Mimics for Efficient siRNA Delivery into Human T Cells. Biomacromolecules 16:3172-9|
|Jung, Joo In; Price, Ashleigh R; Ladd, Thomas B et al. (2015) Cholestenoic acid, an endogenous cholesterol metabolite, is a potent Î³-secretase modulator. Mol Neurodegener 10:29|
|Arieta Kuksin, Christina; Gonzalez-Perez, Gabriela; Minter, Lisa M (2015) CXCR4 expression on pathogenic T cells facilitates their bone marrow infiltration in a mouse model of aplastic anemia. Blood 125:2087-94|
Showing the most recent 10 out of 24 publications